Press Release

Press Release

  • (2023-09-13) Samsung Chooses AimedBio for its First Domestic Investment with 'Life Science Fund'

  • AimedBio_antibody_1.jpg

    - Aimedbio receives equity investment from the "Life Science Fund", an investment fund created by Samsung Biologics, Samsung C&T, and Samsung Bioepis.

    - It is Samsung's fourth investment through the "Life Science Fund", but the first case as domestic investment.

    - They will be collaborating on ADC toolbox co-development and CDO business of AMB001, a KDDF grant-receiving platform.

Contact Us >>